Combinaison d'un antagoniste de l'angiopoietine 2 et d'un antagoniste du VEGF-A et/ou du KDR et/ou du FLTL pour le traitement du cancer

• 收藏
• 分享

专利权人:

Medimmune Limited

发明人:

申请号：

EP11167374.5

公开号：

EP2518083A2

申请日:

2006.12.12

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

The invention relates to agents which possess anti-angiogenic activity and are accordingly useful in methods of treatment of disease states associated with angiogenesis in the animal or human body. More specifically the invention concerns a combination of an antagonist of the biological activity of Angiopoietin-2 and an antagonist of the biological activity of VEGF-A, and/or KDR, and/or Flt1, and uses of such antagonists.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/